Siga Technologies (SIGA) Non-Current Deffered Revenue (2011 - 2018)
Siga Technologies' (SIGA) quarterly Non-Current Deffered Revenue came in at $376.0 million in Q1 2018, little changed YoY from $376.2 million in Q1 2017, and little changed on a QoQ basis from $377.6 million in Q4 2017.
Siga Technologies (SIGA) Non-Current Deffered Revenue (2011 - 2018) Analysis & Trends
Siga Technologies (SIGA) has 8 years of Non-Current Deffered Revenue data on file, last reported at $376.0 million in Q1 2018.
- Quarterly Non-Current Deffered Revenue changed 0.05% year-over-year to $376.0 million in Q1 2018, while the trailing twelve-month figure through Mar 2018 was $376.0 million (changed 0.05% YoY) and the FY2017 annual result came in at $377.6 million, up 2.76% from the prior year.
- Non-Current Deffered Revenue was little changed at $376.0 million in Q1 2018, from $377.6 million in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $377.6 million in Q4 2017 to a low of $81799.0 in Q4 2014.
- A 5-year average of $268.5 million and a median of $271.9 million in 2016 frame the typical range for Non-Current Deffered Revenue.
- Annual changes were most pronounced in 2014 — Non-Current Deffered Revenue tumbled 99.95% — and 2015, when it surged 311955.61%.
- Tracing SIGA's Non-Current Deffered Revenue over 5 years: stood at $81799.0 in 2014, then surged by 311955.61% to $255.3 million in 2015, then surged by 43.97% to $367.5 million in 2016, then gained by 2.76% to $377.6 million in 2017, then retreated by 0.43% to $376.0 million in 2018.
- The last three Non-Current Deffered Revenue figures came in at $376.0 million (Q1 2018), $377.6 million (Q4 2017), and $377.4 million (Q3 2017), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Siga Technologies | 213.02 Mn | 58.06 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 376.03 Mn |
| Dec 31, 2017 | 377.64 Mn |
| Sep 30, 2017 | 377.45 Mn |
| Jun 30, 2017 | 376.48 Mn |
| Mar 31, 2017 | 376.20 Mn |
| Dec 31, 2016 | 367.48 Mn |
| Sep 30, 2016 | 367.12 Mn |
| Jun 30, 2016 | 288.29 Mn |
| Mar 31, 2016 | 255.47 Mn |
| Dec 31, 2015 | 255.26 Mn |
| Sep 30, 2015 | 255.09 Mn |
| Jun 30, 2015 | 233.74 Mn |
| Mar 31, 2015 | 13.53 Mn |
| Dec 31, 2014 | 81,799.00 |
| Jun 30, 2014 | 188.08 Mn |
| Mar 31, 2014 | 187.78 Mn |
| Dec 31, 2013 | 162.22 Mn |
| Sep 30, 2013 | 162.06 Mn |
| Jun 30, 2013 | 119.07 Mn |
| Mar 31, 2013 | 83.51 Mn |